| Literature DB >> 27877883 |
Kazuhiko Ishihara1, Weixin Chen2, Yihua Liu3, Yuriko Tsukamoto2, Yuuki Inoue2.
Abstract
Multifunctional polymeric nanoparticles are materials with great potential for a wide range of biomedical applications. For progression in this area of research, unfavorable interactions of these nanoparticles with proteins and cells must be avoided in biological environments, for example, through treatment of the nanoparticle surfaces. Construction of an artificial cell membrane structure based on polymers bearing the zwitterionic phosphorylcholine group can prevent biological reactions at the surface effectively. In addition, certain bioactive molecules can be immobilized on the surface of the polymer to generate enough affinity to capture target biomolecules. Furthermore, entrapment of inorganic nanoparticles inside polymeric matrices enhances the nanoparticle functionality significantly. This review summarizes the preparation and characterization of cytocompatible and multifunctional polymeric nanoparticles; it analyzes the efficiency of their fluorescence function, the nature of the artificial cell membrane structure, and their performance as in-cell devices; and finally, it evaluates both their chemical reactivity and effects in cells.Entities:
Keywords: 30 Bio-inspired and biomedical materials; 600 Biomaterials, Nano materials; Nanomedicine molecular science; cytocompatibility; fluorescence property; in-cell device; surface modification; zwitterionic polymer
Year: 2016 PMID: 27877883 PMCID: PMC5111563 DOI: 10.1080/14686996.2016.1190257
Source DB: PubMed Journal: Sci Technol Adv Mater ISSN: 1468-6996 Impact factor: 8.090
Figure 1. Cell membrane-inspired molecular design and chemical structure of MPC polymer.
List of nanoparticles covered with MPC polymers
| Pacritaxel | PMBN-EGF | 50–75 | Anti-tumor effect | 49 |
| Pacritaxel | PMBN-per S1 | 50 | Anti-tumor effect | 50 |
| Doxorubicin | P(MPC- | — | Anti-tumor effect | 51 |
| Griseofulvin | PMB30 | 20–50 | Pharmaceutical activity | 52 |
| Tranilast | PMB30 | Solid dispersion | 53 | |
| Cyclosporine A | PMB30 | Solid dispersion | 54 | |
| Plasmid DNA | PMB50 | 190 ± 3 | Transfection effect | 55 |
| DNA/β-CD complex | PMPC-adamantyl | 110–150 | Gene carrier | 56 |
| DNA | PMD-folic acid | 100–165 | Gene carrier | 57 |
| CHP | PMPC | 59.7 ± 27.4 | Self-aggregation | 58 |
| CaCO3, BaCO3 | PMPC | 1,000–3000 | Biomineralization | 59 |
| Graphene oxide | PMPC | 500–1500 | Biomedical application | 60 |
| Magnetic particle | PMPC | Immuno-reaction | 61 | |
| Fe3O4 nanoparticle | PMPC | 18.7 ± 1.5 | Contrast agent of MRI | 62 |
| Fe3O4 nanoparticle | PMPC | 8.9 ± 0.1 | Contrast agent of MRI | 63 |
| Fe3O4/SiO2 | P(MPC- | 630–670 | Molecular imprinting | 64 |
| SiO2 | PMPC | 12 | Stabilizer | 65 |
| Mesoporous SiO2 | PMPC | <1100 | In cell carrier | 66 |
| TiO2 nanoparticle | PMPC | 100 | Suspension in aqueous media | 67 |
| Ag nanoparticle | P(MPC- | 130–160 | Thin film formation | 68 |
| Ag nanoparticle | P(MPC- | 100–500 (Film) | Anti-bacterial activity | 69 |
| Au nanoparticles | PMPC | 100–300 | Protein detection | 70 |
| Au nanorod | P(MPC- | 17.8 ± 1.8 × 53.1 ± 3.5 | Imaging in cell | 71 |
| Pd nanoparticle | PMPC- | Catalyst for coupling | 72 | |
| CdSe/ZnS QD | PMPC | 12 | Imaging in cell | 73 |
| CdSe/ZnS QD | PDbNbM | 20–30 | Tracking in cell | 74 |
| Polystyrene | PMPC-NH2 | 333–611 | Template for Au nanoparticle | 75 |
| Poly(lactic acid) | PMBN | 250–300 | Immobilization of IgG | 76 |
| Poly(lactic acid) | PMB30 | 400–500 | Cell-based assay | 77 |
| Poly(lactic acid) | PMB-PL | 127 | Photoinduced release of protein | 78 |
| Poly(amido amine) | PMPC | 115–156 | Dendorimer dispersion | 79 |
| Poly(BMA) | PMPC | 100 | Near-IR imaging | 80 |
PMPC: poly(MPC), PMB50: water-soluble poly(MPC-co-BMA) MPC unit content 50 mol%, PMBN: poly(MPC-co-BMA-co-MEONP), CHP: cholesteryl groups-bearing pullulan, P(MPC-co-HEMA): poly(MPC-co-hydroxyethyl methacrylate), P(MPC-co-DHLA): poly(MPC-co-methacryloyloxyethyl dihydrolipoic acid), P(MPC-co-AAm): poly(MPC-co-acrylamide), P(MPC-co-EtOEMA): poly(MPC-co-2-ethoxy-2-oxyethyl methacrylate), PMB30: water-soluble poly(MPC-co-BMA) MPC unit content 30 mol%, molecular weight 5.0 × 104, PMD: poly(MPC-co-N,N-dimethylaminoethyl methacrylate (DMAEMA)), PDbNbM: poly(DMAEMA)-block-poly(MEONP)-block-poly(MPC), PMB-PL: poly(MPC-co- BMA-co-4-(4-(1-methacryloyloxyethyl)-2-methoxy-5-nitrophenoxy)butyric acid), PMPC-block-PDiPAMA: poly(MPC-block-2-(N,N-diisopropylamino)ethyl methacrylate).
Figure 2. Schematic representation of QD modified with poly(MPC) (A) and fluorescence microscopy image of QD internalization into cells (B).
Figure 3. Schematic representation of QD modified with pH-responsive triblock-type MPC polymer and its FRET generation in response to pH change.
Figure 4. Schematic representation of the entrapment of QDs by PLA nanoparticles and coating with MPC polymers.
Figure 5. Fluorescence spectra of the QD and PMBN/PLA/QD nanoparticles (A), and fluorescence image of the PMBN/PLA/QD nanoparticles prepared with various sonication times (B).
Figure 6. Morphological observation of PMBN/PLA/QD nanoparticles.
Figure 7. Uptake of the octapeptide-PMBN/PLA/QD nanoparticles by HeLa cells.
Figure 8. Effect of the chemical structure of octapeptide immobilized on PMBN/PLA/QD nanoparticles on cellular internalization. (Reproduced from [102] with copyright permission, Wiley-VCH)
Figure 9. Effect of the sequence of octapeptide immobilized on PMBN/PLA/QD nanoparticles on cellular internalization. Internalization of nanoparticles was evaluated by fluorescence microscopy (upper panel), and the fluorescence intensity was determined for each nanoparticles (lower panel). (Reproduced from [101].)
Figure 10. Effect of composition of R8 and G8 immobilized on PMBN/PLA/QD nanoparticles on cellular internalization.
Figure 11. Distribution of R8-PMBN/PLA/QD nanoparticles in the cells during cell proliferation (upper panel) and relative fluorescence intensity of total microscope area (lower panel). (Reproduced from [102].)